Treatment of Constipation
Start with osmotic laxatives (polyethylene glycol, lactulose, or magnesium salts) or stimulant laxatives (senna, bisacodyl, sodium picosulfate) as first-line pharmacological therapy, combined with non-pharmacological measures including increased fluid intake and physical activity. 1, 2
Initial Assessment
Before initiating treatment, perform a focused evaluation:
- Conduct abdominal examination, perineal inspection, and digital rectal examination to identify fecal impaction or rectal masses 1, 2
- Check corrected calcium and thyroid function if metabolically-driven constipation is suspected (hypercalcemia, hypothyroidism) 1, 2
- Consider plain abdominal X-ray to assess fecal loading extent and exclude bowel obstruction 1, 2
- Identify and discontinue non-essential constipating medications 2
Non-Pharmacological Management (First-Line for All Patients)
Implement these measures before or alongside pharmacological therapy:
- Ensure privacy and comfortable positioning during defecation; a small footstool helps facilitate proper straining mechanics 1, 2
- Increase fluid intake to adequate levels 1, 2
- Increase physical activity and mobility within patient limitations, even bed-to-chair transfers 1, 2
- Add dietary fiber (9-12 g for children under 6 years; 12-18 g for older children and adults) only if fluid intake is adequate 1, 2, 3
- Consider abdominal massage, particularly for patients with neurogenic bowel dysfunction 1, 2
Pharmacological Treatment Algorithm
Standard Constipation (Non-Opioid-Induced)
First-line laxatives:
Osmotic laxatives: Polyethylene glycol (PEG 17 g/day), lactulose, or magnesium salts 1, 2
Stimulant laxatives: Senna, bisacodyl (10-15 mg, 2-3 times daily), cascara, or sodium picosulfate 1, 2
- Goal: 1 non-forced bowel movement every 1-2 days 1
Second-line options if first-line fails:
- Rectal bisacodyl once daily 1
- Secretagogues (linaclotide, lubiprostone, plecanatide) for refractory cases 1
- Prokinetic agents (metoclopramide) if gastroparesis is suspected 1
Opioid-Induced Constipation (OIC)
Prophylaxis is mandatory:
- Prescribe a concomitant laxative with all opioid therapy unless pre-existing diarrhea is present 1, 2
- Use osmotic or stimulant laxatives as first-line 1, 2
For refractory OIC:
- Methylnaltrexone 0.15 mg/kg subcutaneously every other day (maximum once daily) for constipation unresponsive to standard laxatives 1, 2
- Contraindicated in postoperative ileus or mechanical bowel obstruction 1
- Naloxegol (peripherally-acting μ-opioid receptor antagonist) as alternative 1
- Combined opioid/naloxone preparations reduce OIC risk 1
- Lubiprostone (prostaglandin analog) can be combined with methylnaltrexone 1
Fecal Impaction
When digital rectal examination identifies impaction:
- Perform digital fragmentation and manual extraction of stool 1, 2
- Administer glycerin suppositories for less severe impaction 1
- Use suppositories and enemas as first-line therapy when rectum is full on examination 1, 2
- Follow with maintenance bowel regimen to prevent recurrence 1, 2
Enema contraindications: neutropenia, thrombocytopenia, paralytic ileus, intestinal obstruction, recent colorectal/gynecological surgery, recent anal/rectal trauma, severe colitis, toxic megacolon, undiagnosed abdominal pain, or recent pelvic radiotherapy 1
Special Populations
Elderly Patients
- Use PEG 17 g/day as preferred agent due to excellent safety profile 1, 2
- Ensure toilet access, especially with decreased mobility 1, 2
- Educate on optimal toileting: attempt defecation twice daily, 30 minutes after meals, strain no more than 5 minutes 1
- Avoid liquid paraffin in bedridden patients or those with swallowing disorders due to aspiration lipoid pneumonia risk 1, 2
- Use saline laxatives (magnesium hydroxide) cautiously due to hypermagnesemia risk 1
- Monitor closely if on diuretics or cardiac glycosides for dehydration and electrolyte imbalances 1, 2
- Prefer isotonic saline enemas over sodium phosphate enemas to minimize adverse effects 1
Common Pitfalls
- Do not add fiber without adequate fluid intake as this worsens constipation 1, 2
- Avoid bulk agents in non-ambulatory patients with low fluid intake due to mechanical obstruction risk 1
- Do not use psyllium for opioid-induced constipation as it is ineffective 1
- Remember that complete symptom resolution is often unachievable; manage patient expectations accordingly 1